United States

Aura Biosciences is a biotech company focused on developing therapies for cancer treatment. They use a virus-like drug conjugates (VDC) technology platform to target tumors in ocular and urologic oncology. Their main candidate, AU-011, is being developed for the treatment of primary choroidal melanoma and other ocular oncology indications. The company was founded in 2009 and is based in Cambridge, Massachusetts.

Google

Produkto vadovas

Duomenų mokslininkas

Aura Biosciences

Aura Biosciences Atviros pozicijos

Ar pasiruošę kelti savo karjerą? Peržiūrėkite šias atviras pozicijas Aura Biosciences įmonėje.